These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3145996

  • 1. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
    Yoshioka A.
    Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
    [No Abstract] [Full Text] [Related]

  • 2. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S, Yorifuji H, Arai M, Fukutake K.
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract] [Full Text] [Related]

  • 3. Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.
    Levine PH.
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-2. PubMed ID: 3133770
    [No Abstract] [Full Text] [Related]

  • 4. [New prospects in the treatment of hemophilia. High-purity concentrates of factor VIII].
    Tusell Puigbert JM.
    Med Clin (Barc); 1993 May 01; 100(17):655-8. PubMed ID: 8497171
    [No Abstract] [Full Text] [Related]

  • 5. Factor VIII concentrate: what is "high purity"?
    Schoppmann A, Weber A, Hondl F, Linnau Y.
    Thromb Haemost; 1994 Sep 01; 72(3):483-4. PubMed ID: 7855803
    [No Abstract] [Full Text] [Related]

  • 6. [Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].
    Weisser J.
    Klin Padiatr; 1988 Sep 01; 200(5):375-9. PubMed ID: 3141670
    [Abstract] [Full Text] [Related]

  • 7. [Improvement in anti-hemophilic preparations and its problems. 7. Present status and future aspect of anti-hemophilic preparations].
    Kamiya T.
    Rinsho Ketsueki; 1988 May 01; 29(5):666-70. PubMed ID: 3145998
    [No Abstract] [Full Text] [Related]

  • 8. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1987 Mar 13; 36(9):121-4. PubMed ID: 3102937
    [No Abstract] [Full Text] [Related]

  • 9. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE, Smith JK.
    Thromb Haemost; 1982 Aug 24; 48(1):46-8. PubMed ID: 6813994
    [Abstract] [Full Text] [Related]

  • 10. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV, Griffin B, Pepper DS, Dickson AJ, McQuillan TA, Dickson IH, Foster PR.
    Thromb Haemost; 1981 Oct 24; 46(3):597-601. PubMed ID: 6797090
    [Abstract] [Full Text] [Related]

  • 11. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF.
    Adv Pediatr; 1984 Oct 24; 31():137-77. PubMed ID: 6440429
    [No Abstract] [Full Text] [Related]

  • 12. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA, Nováková IR, Haanen C.
    Ned Tijdschr Geneeskd; 1989 Jun 10; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract] [Full Text] [Related]

  • 13. Factor VIII/von Willebrand factor.
    Zimmerman TS, Ruggeri ZM, Fulcher CA.
    Prog Hematol; 1983 Jun 10; 13():279-309. PubMed ID: 6422506
    [No Abstract] [Full Text] [Related]

  • 14. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V.
    Sangre (Barc); 1989 Feb 10; 34(1):1-3. PubMed ID: 2496481
    [No Abstract] [Full Text] [Related]

  • 15. [Factor VIII concentrates].
    Faber JC.
    Bull Soc Sci Med Grand Duche Luxemb; 1986 Feb 10; 123(2):27-9. PubMed ID: 3100076
    [No Abstract] [Full Text] [Related]

  • 16. High purity factor VIII and immune state in HIV.
    Nurs Stand; 1986 Feb 10; 8(3):17. PubMed ID: 8217692
    [No Abstract] [Full Text] [Related]

  • 17. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 10; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 18. [Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
    Gutsalo AE, Varetskaia TV, Kozulina EP, Papaian LP.
    Ukr Biokhim Zh (1978); 1995 Nov 10; 67(1):3-13. PubMed ID: 8588250
    [Abstract] [Full Text] [Related]

  • 19. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM.
    Wien Klin Wochenschr; 1982 Oct 15; 94(19):509-14. PubMed ID: 6818773
    [Abstract] [Full Text] [Related]

  • 20. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H, Takase T.
    Rinsho Ketsueki; 1985 Jul 15; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.